ロード中...
Anti-TNF Withdrawal in Inflammatory Bowel Disease
The introduction of the anti-tumor necrosis factorα agents (anti-TNFα) in clinical practice has greatly advanced the treatment of inflammatory bowel disease. The use of these medications results in durable remission in a subset of patients, preventing surgery and hospitalizations. However, there are...
保存先:
| 出版年: | GE Port J Gastroenterol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Karger Publishers
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5580146/ https://ncbi.nlm.nih.gov/pubmed/28868451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpge.2015.11.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
ロード中...